Rating History for Progenics Pharmaceuticals (PGNX) by Credit Suisse

More Stocks Rated by Credit Suisse | Latest Ratings for PGNX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
12/7/2018 N/A New Coverage Outperform
(N/A)		 6.50
(N/A)		 4.64
(4.10)		 -11.64% Details